Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - midazolam - oromucosal solution - midazolam

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - midazolam - oromucosal solution - midazolam

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - midazolam - oromucosal solution - midazolam

Canada - English - Health Canada

pfizer canada ulc - midazolam - solution - 1mg - midazolam 1mg - benzodiazepines

Canada - English - Health Canada

pfizer canada ulc - midazolam - solution - 5mg - midazolam 5mg - benzodiazepines

United States - English - NLM (National Library of Medicine)

atlantic biologicals corp. - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam hcl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. midazolam hcl syrup is intended for use in monitored settings only and not for chronic or home use (see warnings). midazolam is contraindicated in patients with a known hypersensitivity to the drug or allergies to formulation excipients. benzodiazepines are contraindicated in patients with acute narrow-angle glaucoma. benzodiazepines may be used in patients with open-angle glaucoma only if they are receiving appropriate therapy. measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction of general anesthesia with injectable midazolam; patients with glaucoma have not been studied. midazolam hcl syrup is a benzodiazepine and is a schedule iv controlled substance that can produce drug dependence of the diazepam-type. therefore, midazolam hcl syrup may be subject to mis

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - midazolam hydrochloride (unii: w7ttw573jj) (midazolam - unii:r60l0sm5bc) - midazolam hcl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. midazolam hcl syrup is intended for use in monitored settings only and not for chronic or home use (see warnings). midazolam is contraindicated in patients with a known hypersensitivity to the drug or allergies to formulation excipients. benzodiazepines are contraindicated in patients with acute narrow-angle glaucoma. benzodiazepines may be used in patients with open-angle glaucoma only if they are receiving appropriate therapy. measurements of intraocular pressure in patients without eye disease show a moderate lowering following induction of general anesthesia with injectable midazolam; patients with glaucoma have not been studied. midazolam hcl syrup is a benzodiazepine and is a schedule iv controlled substance that can produce drug dependence of the diazepam-type. therefore, midazolam hcl syrup may be subject to mis

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - midazolam 1 mg/ml;   - solution for injection - 1 mg/ml - active: midazolam 1 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - midazolam 5 mg/ml;   - solution for injection - 5 mg/ml - active: midazolam 5 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).

Israel - English - Ministry of Health

rafa laboratories ltd - midazolam - solution for injection - midazolam 1 mg/ml - midazolam - midazolam - midazolam is a short-acting sleep-inducing drug that is indicated:in adults• conscious sedation before and during diagnostic or therapeutic procedures with or without local anaesthesia• anaesthesia- premedication before induction of anaesthesia- induction of anaesthesia- as a sedative component in combined anaesthesia• sedation in intensive care unitsin children• conscious sedation before and during diagnostic or therapeutic procedures with or without local anaesthesia• anaesthesia- premedication before induction of anaesthesia• sedation in intensive care units